This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Alexander Marme: Innovator in Preeclampsia Research
Introduction
Alexander Marme is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of preeclampsia. His work focuses on the role of specific genes and their products in understanding and addressing this serious condition.
Latest Patents
Marme holds a patent titled "Use of ADAM 12 for diagnosis and therapy of preeclampsia." This invention highlights the significant role of ADAM 12, ADAM 12-L, and ADAM 12-S in preeclampsia and related disorders. The patent outlines the use of these genes and their products, as well as ligands that bind to them, in the diagnosis and treatment of preeclampsia and related syndromes. Furthermore, it discusses the potential for using additional genes and combinations thereof in diagnosing these conditions.
Career Highlights
Alexander Marme is affiliated with the Deutsches Krebsforschungszentrum, where he conducts his research. His work has been instrumental in advancing the understanding of preeclampsia, a condition that poses significant risks to both mothers and infants during pregnancy. His innovative approach has opened new avenues for diagnosis and treatment.
Collaborations
Marme has collaborated with esteemed colleagues such as Gunnar Wrobel and Peter Lichter. These partnerships have enhanced the depth and impact of his research, contributing to the collective knowledge in the field of preeclampsia.
Conclusion
In summary, Alexander Marme is a pioneering inventor whose work in the diagnosis and treatment of preeclampsia has the potential to significantly improve maternal and infant health outcomes. His contributions to medical research are invaluable and continue to inspire further innovations in the field.